Weir Matthew R., Espaillat Ramon
Postgraduate medicine, 2015
Abstract
Hypokalemia is a common electrolyte disturbance, observed in > 20% of hospitalized patients. Hypokalemia, although not formally defined, is generally considered to be when serum potassium levels fall below the normal value of 3.6 mmol/L. In contrast to other electrolytes, potassium is primarily an intracellular ion: only 2% of all potassium in the body is present in the extracellular fluid, so a small decrease in serum potassium may represent a significant decrease in intracellular potassium. Individuals with mildly decreased potassium levels (3.0-3.5 mmol/L) may be asymptomatic, but patients with more pronounced decreases may report symptoms including muscle weakness, fatigue, and constipation. Very low serum potassium levels (≤ 2.5 mmol/L) can lead to muscle necrosis, paralysis, cardiac arrhythmias, and impaired respiration, which can be life-threatening. Absent comprehensive and robust treatment guidelines, strategies for the prevention or treatment of hypokalemia, such as how to diagnose hypokalemia, when to treat patients, what dosage regimen of potassium supplementation to use and for how long, are often based on the experience of the physician and empirical evidence. However, proper evaluation and treatment of hypokalemia in patients is essential because of associated morbidities. Because small potassium deficits in serum represent large body losses, potassium repletion requires substantial and prolonged supplementation. For patients with known risk factors for hypokalemia (e.g. hypertension, heart failure, or diabetes), careful monitoring is crucial to avoid the adverse sequelae associated with potassium deficits and to ensure that adequate and timely preventive measures can be taken. In this review, we provide practical insights into the etiology, differential diagnosis, and treatment of hypokalemia, including treatment strategies for patients with known risk factors.
Keywords
Heart failure; hypertension; hypokalemia; potassium
| PMID: | 25960118 |
|---|---|
| Category: | General properties of Potassium |
Articles similar to "Clinical perspectives on the rationale for potassium supplementation."
- The properties of Potassium: Potassium intake, bioavailability, hypertension, and glucose control. (Potassium is an essential nutrient...)
- The properties of Potassium: Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials. (IMPORTANCE: Increased dietary potassium intake is thought to be associated with low blood pressure (BP)... Our findings indicated that potassium supplementation is a safe medication with no important adverse effects that has a modest but significant impact BP and may be recommended as an adjuvant antihypertensive agent for patients with essential hypertension.)
- The properties of Potassium: The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. ( Several intervention studies have investigated the relation between potassium intake and blood-pressure, particularly in hypertensive subjects... Potassium supplementation in hypertensives was generally associated with decreased blood pressure, particularly in high sodium consumers, subjects not on hypertensive drug treatment, and those in the lowest category of potassium intake. An adequate dietary intake of potassium, in the order of 90mmol/day, should be achieved for blood pressure control. )
- The properties of Potassium: Potassium chloride supplementation diminishes platelet reactivity in humans. (The prevalence of occlusive stroke is inversely correlated with potassium intake... Potassium supplementation in hypertensives was generally associated with decreased blood pressure, particularly in high sodium consumers, subjects not on hypertensive drug treatment, and those in the lowest category of potassium intake. An adequate dietary intake of potassium, in the order of 90mmol/day, should be achieved for blood pressure control. )
- The properties of Potassium: Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. (Randomized trials have shown that increasing potassium intake lowers blood pressure... Potassium supplementation in hypertensives was generally associated with decreased blood pressure, particularly in high sodium consumers, subjects not on hypertensive drug treatment, and those in the lowest category of potassium intake. An adequate dietary intake of potassium, in the order of 90mmol/day, should be achieved for blood pressure control. )